A Pill to Treat COVID-19 and the Shape of Things to Come
By Robert J. Kriss, C2ST Editor
Pfizer recently used the Advanced Photon Source (“APS”), a powerful x-ray machine operated by the U.S. Department of Energy’s Argonne National Laboratory, to help them develop a pill that appears to reduce the risk of hospitalization and death among COVID-19 patients by 89%. Pfizer is now seeking FDA approval to administer the drug to patients. The process Pfizer used to develop this pill may be the blueprint for preventing future pandemics.
Continue reading “A Pill to Treat COVID-19 and the Shape of Things to Come”